California State Teachers Retirement System Xencor Inc Transaction History

California State Teachers Retirement System

  • $84.1 Billion
  • Q3 2024

A detailed history of California State Teachers Retirement System transactions in Xencor Inc stock. As of the latest transaction made, California State Teachers Retirement System holds 52,754 shares of XNCR stock, worth $1.27 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
52,754
Previous 54,192 2.65%
Holding current value
$1.27 Million
Previous $1.03 Million 3.41%
% of portfolio
0.0%
Previous 0.0%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
SELL
$15.7 - $21.65 $22,576 - $31,132
-1,438 Reduced 2.65%
52,754 $1.06 Million
Q2 2024

Aug 14, 2024
SELL
$18.21 - $24.5 $16,571 - $22,295
-910 Reduced 1.65%
54,192 $1.03 Million
Q1 2024

May 15, 2024
SELL
$18.65 - $26.52 $55,651 - $79,135
-2,984 Reduced 5.14%
55,102 $1.22 Million
Q4 2023

Feb 13, 2024
SELL
$16.53 - $21.42 $45,589 - $59,076
-2,758 Reduced 4.53%
58,086 $1.23 Million
Q3 2023

Nov 14, 2023
SELL
$20.08 - $25.39 $120,279 - $152,086
-5,990 Reduced 8.96%
60,844 $1.23 Million
Q2 2023

Aug 21, 2023
SELL
$24.77 - $29.9 $112,331 - $135,596
-4,535 Reduced 6.35%
66,834 $1.67 Million
Q1 2023

May 09, 2023
SELL
$25.95 - $36.95 $22,265 - $31,703
-858 Reduced 1.19%
71,369 $1.99 Million
Q4 2022

Feb 14, 2023
BUY
$24.79 - $30.86 $21,914 - $27,280
884 Added 1.24%
72,227 $1.88 Million
Q3 2022

Nov 18, 2022
SELL
$24.62 - $32.44 $19,769 - $26,049
-803 Reduced 1.11%
71,343 $1.85 Million
Q2 2022

Aug 15, 2022
BUY
$19.74 - $29.01 $62,200 - $91,410
3,151 Added 4.57%
72,146 $1.98 Million
Q1 2022

May 16, 2022
SELL
$26.68 - $41.63 $168,244 - $262,518
-6,306 Reduced 8.37%
68,995 $1.84 Million
Q4 2021

Feb 15, 2022
BUY
$33.67 - $43.44 $64,006 - $82,579
1,901 Added 2.59%
75,301 $3.02 Million
Q3 2021

Nov 15, 2021
SELL
$30.65 - $35.68 $143,350 - $166,875
-4,677 Reduced 5.99%
73,400 $2.4 Million
Q2 2021

Aug 16, 2021
SELL
$34.33 - $44.68 $190,909 - $248,465
-5,561 Reduced 6.65%
78,077 $2.69 Million
Q1 2021

May 18, 2021
SELL
$40.81 - $53.88 $9,263 - $12,230
-227 Reduced 0.27%
83,638 $3.6 Million
Q4 2020

Feb 16, 2021
SELL
$36.63 - $47.63 $7,399 - $9,621
-202 Reduced 0.24%
83,865 $3.66 Million
Q3 2020

Nov 17, 2020
BUY
$30.09 - $43.02 $13,961 - $19,961
464 Added 0.56%
84,067 $3.26 Million
Q2 2020

Aug 17, 2020
BUY
$27.76 - $33.42 $324,708 - $390,913
11,697 Added 16.27%
83,603 $2.71 Million
Q1 2020

May 13, 2020
SELL
$20.69 - $37.79 $7,386 - $13,491
-357 Reduced 0.49%
71,906 $2.15 Million
Q4 2019

Feb 14, 2020
SELL
$32.75 - $41.43 $47,782 - $60,446
-1,459 Reduced 1.98%
72,263 $2.49 Million
Q3 2019

Nov 15, 2019
BUY
$33.73 - $46.27 $29,682 - $40,717
880 Added 1.21%
73,722 $2.49 Million
Q2 2019

Aug 14, 2019
BUY
$29.6 - $40.93 $38,598 - $53,372
1,304 Added 1.82%
72,842 $2.98 Million
Q1 2019

May 09, 2019
SELL
$27.85 - $38.09 $44,309 - $60,601
-1,591 Reduced 2.18%
71,538 $2.22 Million
Q4 2018

Feb 13, 2019
BUY
$32.39 - $42.05 $77,833 - $101,046
2,403 Added 3.4%
73,129 $2.64 Million
Q3 2018

Nov 14, 2018
SELL
$35.69 - $47.65 $142 - $190
-4 Reduced 0.01%
70,726 $2.76 Million
Q2 2018

Aug 14, 2018
BUY
$28.41 - $42.41 $362,255 - $540,769
12,751 Added 21.99%
70,730 $2.62 Million
Q1 2018

May 15, 2018
SELL
$21.18 - $33.78 $43,482 - $69,350
-2,053 Reduced 3.42%
57,979 $1.74 Million
Q4 2017

Feb 14, 2018
SELL
$19.29 - $24.83 $11,651 - $14,997
-604 Reduced 1.0%
60,032 $1.32 Million
Q3 2017

Nov 13, 2017
BUY
$19.61 - $23.35 $1.19 Million - $1.42 Million
60,636
60,636 $1.39 Million

Others Institutions Holding XNCR

# of Institutions
215
Shares Held
71.5M
Call Options Held
2.5K
Put Options Held
7.9K
View Full List

About Xencor Inc

XNCR Quotes by TradingView
  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.44B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track California State Teachers Retirement System Portfolio

Follow California State Teachers Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California State Teachers Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California State Teachers Retirement System with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email